Department of Pathology Microbiology and Immunology

Obesity-cancer connection discovery suggests strategies for improving immunotherapy 

The study reported in the journal Nature provides a mechanistic explanation for the “obesity paradox” — that obesity can contribute to cancer progression but also improve response to immunotherapy.

(iStock image)

Jennifer Gordetsky honored for her history of urology research

Jennifer Gordetsky, MD, believes the most important part of medical history is making sure our mistakes are not forgotten

Jeffrey Rathmell, PhD, and Melissa Wolf, PhD. (photo by Susan Urmy)

Study reveals potential new way to stop a common kidney cancer

Vanderbilt researchers have identified cancer cell-specific genetic alterations that reprogram the immune “landscape,” thereby driving tumor growth, and discovered a potential new drug target for stopping it.

Mariana Byndloss, DVM, PhD

Mariana Byndloss receives FASEB Excellence in Science Award

The annual awards highlight outstanding achievements by women in the biological sciences.

From left, Jennifer Pietenpol, PhD, Eric Farber-Eger, Lauren LeStourgeon, MPH, Luisella Spiga, PhD, and John Kuriyan, PhD.

VUMC research staff honored for excellence in the lab, clinic

Laboratory and administrative personnel at Vanderbilt University Medical Center were honored on March 29 for research excellence during the 20th annual Research Staff Awards Ceremony.

From left, Simon Mallal, MBBS, and John Koethe, MD, MSCI. (photo by Susan Urmy)

VUMC’s John Koethe named director of the Tennessee Center for AIDS Research

John Koethe, MD, MSCI, associate professor of Medicine in the Division of Infectious Diseases at Vanderbilt University Medical Center, has been appointed director and principal investigator of the Tennessee Center for AIDS Research.

1 2 3 30